Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
83.25 USD | -0.30% | -0.63% | -13.66% |
06-27 | Wells Fargo Adjusts BioMarin Pharmaceutical Price Target to $115 From $110, Maintains Overweight Rating | MT |
06-24 | BioMarin Pharmaceutical Inc.(NasdaqGS:BMRN) added to S&P 1000 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.66% | 15.85B | |
+2.99% | 94.76B | |
-4.34% | 37.58B | |
-10.30% | 33.3B | |
+75.41% | 27.92B | |
-3.74% | 13.79B | |
-12.31% | 11.51B | |
+184.77% | 10.9B | |
-53.94% | 9.27B | |
+5.77% | 9.09B |
- Stock Market
- Equities
- BMRN Stock
- News BioMarin Pharmaceutical Inc.
- Sector Update: Health Care Stocks Rise Late Afternoon